Biological E Will Produce the Johnson and Johnson COVID Vaccine

20 May 2021 Current Affairs:Biological E will produce Johnson and Johnson COVID-19 vaccines along with its own vaccine. This is to increase the country’s total vaccine production. The US Food and Drug Administration and the World Health Organization have also approved it. Johnson and Johnson has applied for approval to perform clinical trials in India.

Highlights:
♦ India’s Biological E will deliver 600 million Johnson and Johnson Vaccine doses per year.
♦ It will manufacture both the Johnson and Johnson vaccine and its own vaccine.
♦ The vaccine manufacturing units, on the other hand, would be different. In addition, the United States will finance the manufacture of Johnson and Johnson vaccines.
♦ In Hyderabad, Biological E plans to manufacture 75 million to 80 million doses of its own vaccine.
♦ Baylor College of Medicine in Houston developed the drug.
 

Leave a Reply

Your email address will not be published. Required fields are marked *